Description: Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Home Page: www.kezarlifesciences.com
KZR Technical Analysis
4000 Shoreline Court
South San Francisco,
CA
94080
United States
Phone:
650 822 5600
Officers
| Name | Title |
|---|---|
| Mr. John Franklin Fowler | Co-Founder, CEO & Director |
| Dr. Christopher J. Kirk Ph.D. | Co-Founder, Pres, Chief Scientific Officer & Director |
| Dr. Noreen Roth Henig M.D. | Chief Medical Officer |
| Dr. Jack Taunton Ph.D. | Co-Founder |
| Mr. Marc L. Belsky | CFO & Sec. |
| Mr. Michael Wolfe | Sr. VP of Fin. & Bus. Operations |
| Ms. Gitanjali Jain | VP of Investor Relations & External Affairs |
| Mr. Mark Schiller | Sr. VP of Legal Affairs |
| Dr. Neel K. Anand Ph.D. | VP of Medicinal Chemistry & Head of Drug Discovery |
| Dr. Nick Mordwinkin Ph.D., Pharm.D. | Chief Bus. Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6878 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2018-06-21 |
| Fiscal Year End: | December |
| Full Time Employees: | 56 |